Case Report
Acute Hepatitis A and Hepatitis B Coinfection in a Young Female: A Case Report and Literature Review
Table 1
Laboratory findings during treatment and within one month of follow-up.
| Laboratory tests | On admission (before treatment) | 3 days after treatment | 7 days after treatment | 2 weeks after treatment | One month after treatment |
| AST | 2600 U/L | 1547 U/L | 189 U/L | 22 U/L | 17 U/L | ALT | 3590 U/L | 2180 U/L | 254 U/L | 26 U/L | 21 U/L | ALP | 432 U/L | 337 U/L | 328 U/L | 298 U/L | 287 U/L | Bili.T | 15.8 mg/dL | 8.3 mg/dL | 1.7 mg/dL | 1.16 mg/dL | 1.1 mg/dL | Bili.D | 9 mg/dL | 4.5 mg/dL | 0.9 mg/dL | 0.7 mg/dL | 0.5 mg/dL | PT | 18 | 16.2 | 14 | 12 | 12 | PTT | 41 | 37 | 33.5 | 32 | 28 | INR | 1.51 | 1.4 | 1.25 | 1.1 | 1 |
|
|
AST: aspartate aminotransferase, ALT: alanine aminotransferase, ALP: alkaline phosphatase, Bili.T: total bilirubin, Bili.D: direct bilirubin, PTT: partial thromboplastin time, PT: prothrombin time, INR: international normalized ratio.
|